Home » Topics » Regulatory

Regulatory
RSS

Japanese approval for new formulation of Fosrenol

Feb. 3, 2012

FDA approves ivacaftor for rare form of cystic fibrosis

Feb. 1, 2012

Jentadueto approved in U.S.

Jan. 31, 2012

FDA approves first treatment for advanced BCC

Jan. 31, 2012

FDA approves axitinib for advanced renal cell carcinoma

Jan. 30, 2012

Indication for Gadovist 1.0 is expanded

Jan. 30, 2012

FDA expands Keppra indication

Jan. 26, 2012

FDA approves gel for actinic keratosis

Jan. 26, 2012

Extended indication for Rebif approved in E.U.

Jan. 25, 2012

FDA approves subcutaneous Velcade

Jan. 24, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...